オプションチェーンは、Gyre Therapeuticsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Gyre Therapeuticsの市場センチメントを評価します。.

Gyre Therapeutics (NASDAQ:GYRE) 株価情報, オプションチェーン

Gyre Therapeutics

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

Gyre Therapeutics Inc

Bath &amp; Body Works Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) shares traded higher in premarket on Thursday after the company reported <a href="https://www.benzinga.com/pressreleases/25/05/g45665432/bath-body-works-reports-2025-first-quarter-results-and-maintains-fiscal-year-2025-guidance" target="_blank" rel="noreferrer noopener">first-quarter fiscal 2025</a> results.
The company posted a 2.9% year-over-year increase in sales to $1.42 billion, which is in line with analyst expectations. Earnings per share rose to 49 cents from 38 cents a year ago, topping the consensus estimate of 46 cents.
Gross profit rose 6.6% year over year to $646 million, with gross margin improving 160 basis points to 45.4%. Operating income climbed 11.8% to $209 million, with an operating margin of 14.7%.
Bath &amp; Body Works held $636 million in cash and equivalents as of May 3, 2025. At the end of the quarter, inventories increased 6.8% YoY to $869 million.
The operating cash flow for the quarter totaled $188 million, up from $86 million a year ago.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/05/45518304/these-analysts-boost-their-forecasts-on-bath-body-works" rel="noreferrer noopener">These Analysts Boost Their Forecasts On Bath &amp; Body Works</a>
&#8220;Our team delivered a strong start to the year driven by the positive customer response to our innovation in the quarter. We&#8217;re effectively leveraging our predominantly U.S.-based supply chain to navigate the evolving trade environment, and I&#8217;m confident in our ability to adapt to meet the consumer where they are with fragrance innovation and high-quality product at compelling price points as we move through 2025,&#8221; said Eva Boratto, CFO of Bath &amp; Body Works.  
Last week, the company announced that its independent directors unanimously <a href="https://www.benzinga.com/pressreleases/25/05/g45491656/bath-body-works-appoints-daniel-heaf-as-chief-executive-officer" target="_blank" rel="noreferrer noopener">appointed</a> Daniel Heaf as CEO, effective May 16, 2025. Following the 2025 Annual Meeting of Shareholders, Heaf was also appointed to the Board of Directors.
Outlook: Bath &amp; Body Works reaffirmed its full-year 2025 outlook, projecting net sales growth of 1% to 3% and earnings per share between $3.25 and $3.60 versus the consensus of $3.57. The forecast includes the impact of current tariffs and $300 million in planned share repurchases.
Free cash flow is expected to range from $750 million to $850 million.
For the second quarter, the company expects flat to 2% sales growth and EPS of $0.33 to $0.38 versus the consensus of $0.42, including tariff impacts. Guidance excludes the estimated $0.05 per share impact from the CEO transition.
Price Action: At last check Thursday, BBWI shares were trading higher by 2.53% at $31.25 in the premarket.
Read Next:
<a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45667660/costco-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call-2" rel="noreferrer noopener">Costco Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>
Photo: Shutterstock

Earnings

News

Guidance

BBWI

Bath & Body Works Beats Q1 Estimates, Reaffirms Outlook As New CEO Steps In

IND submission planned for mid-2025 with Phase 1 SAD data anticipated by year end
BGE-102 induced weight loss in preclinical obesity models, both as monotherapy and in combination with GLP-1 receptor agonists Internally discovered compound has a novel binding site and potential best-in-class profile supporting once daily dosing

BIOA

BioAge Labs Completes IND-Enabling Studies For BGE-102 And Advances Candidate Toward Clinic

Wells Fargo analyst Andrew Nowinski downgrades SentinelOne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) from Overweight to Equal-Weight and lowers the price target from $22 to $18.

Downgrades

Price Target

Analyst Ratings

Wells Fargo Downgrades SentinelOne to Equal-Weight, Lowers Price Target to $18

EGHT

8x8 Inc. Promotes Creovai To SoldBy8 Tier Within 8x8 Technology Partner Ecosystem

Contracts

C3 AI Announces US Air Force Has Raised Contract Ceiling To $450M Through Oct. 2029

WIIM

SAGT

SAGT stock has given up its prior gain. SAGTEC GLOBAL shares were trading higher after the company announced its intent to acquire Smart Bridge.

TENB

Tenable To Acquire Apex Security, Terms Not Disclosed

Expansion builds on the companies' successful collaboration in the U.S., further underscoring the value of Affirm's flexible and transparent pay-over-time options across borders
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.affirm.com%2Fen-ca%2F&amp;esheet=54261752&amp;newsitemid=20250529904934&amp;lan=en-US&amp;anchor=Affirm&amp;index=1&amp;md5=5e75075ef7f2dcccabe0dd84b2a66fff">Affirm</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>), the payment network that empowers consumers and helps merchants drive growth, today announced the expansion of its partnership with <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.williams-sonomainc.com&amp;esheet=54261752&amp;newsitemid=20250529904934&amp;lan=en-US&amp;anchor=Williams-Sonoma%2C+Inc.&amp;index=2&amp;md5=3fa8fb735e8f21553132e677da8df6b6">Williams-Sonoma, Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) into Canada. This builds on the companies' multi-year partnership in the U.S. and brings Affirm to Canadians shopping at Williams-Sonoma, Inc.'s family of brands including Williams Sonoma, West Elm, Pottery Barn, Pottery Barn Teen, Pottery Barn Kids, and Mark &amp; Graham.
Whether shopping for a sofa at their local West Elm or furnishing a new nursery with Pottery Barn Kids, approved Canadian shoppers can now split their purchases into monthly payments with Affirm. The process is simple: after selecting Affirm at checkout, consumers go through a quick, real-time eligibility check. If approved, they can choose the customized payment plan that best suits their needs and rest assured that they will never pay any late or hidden fees.

AFRM

Affirm Expands Partnership With Williams-Sonoma Into Canada, Extending Flexible Payment Options

Stock Split

MULN

Mullen Automotive Announces 1-For-100 Reverse Stock Split

Taiwan Semiconductor's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) short percent of float has fallen 6.45% since its last report. The company recently reported that it has 30.09 million shares sold short, which is 0.58% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.95 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Taiwan Semiconductor Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748523639_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Taiwan Semiconductor has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Taiwan Semiconductor's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Taiwan Semiconductor's peer group average for short interest as a percentage of float is 5.79%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

How Do Investors Really Feel About Taiwan Semiconductor?

William Blair analyst Tim Mulrooney downgrades WillScot Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WSC#NASDAQ">WSC</a>) from Outperform to Market Perform.

William Blair Downgrades WillScot Holdings to Market Perform

Offerings

CRML

Critical Metals Corp. Raises $2M Through Exercise Of 400K Warrants At $5.00 Each, Unlocks Additional 1.2M Shares; Plans To Use Proceeds To Advance Critical Mineral Projects In Greenland And Europe

CME Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CME#NYSE">CME</a>) short percent of float has fallen 5.71% since its last report. The company recently reported that it has 4.74 million shares sold short, which is 1.32% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.16 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>CME Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748523634_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CME Group has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing CME Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, CME Group's peer group average for short interest as a percentage of float is 4.24%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About CME Group?

IDT's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDT#NYSE">IDT</a>) short percent of float has risen 69.83% since its last report. The company recently reported that it has 371 thousand shares sold short, which is 1.97% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.59 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>IDT Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748523629_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for IDT has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing IDT's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, IDT's peer group average for short interest as a percentage of float is 1.30%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on IDT?

Citigroup analyst Thomas Palmer reinstates Kellanova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>) with a Neutral and announces $83.5 price target.

Initiation

Citigroup Reinstates Neutral on Kellanova, Announces $83.5 Price Target

Allina Health's new AI agent, "Alli," streamlines patient access and frees customer experience representatives to focus on complex needs

SOUN

SoundHound AI Partners With Allina Health To Launch AI Agent For Patient Engagement

Citigroup analyst Jason Bazinet downgrades Paramount Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>) from Buy to Neutral and lowers the price target from $13 to $12.

PARA

Citigroup Downgrades Paramount Glb to Neutral, Lowers Price Target to $12

ICD Becomes Shareholder in CAAP
Corporación América Airports S.A. (NYSE:<a href="https://www.benzinga.com/stock/CAAP#NYSE">CAAP</a>), ("CAAP" or the "Company"), one of the world's leading private airport operators, announced today that it has acquired, through a wholly-owned subsidiary, the remaining 25% interest in Corporación América Italia S.p.A. ("CAI") from the Investment Corporation of Dubai ("ICD"), thereby increasing its total interest in CAI to 100%. CAI holds a 62.28% interest in Toscana Aeroporti S.p.A. ("TA"), the Company's subsidiary that operates the Pisa and Florence airports.
The transaction was completed through a share swap agreement, with CAAP delivering 1,996,439 newly issued shares to ICD as consideration for the 25% interest in CAI. To ensure a fair valuation, an internationally recognized firm was engaged to provide an independent fairness opinion.
With this acquisition, CAAP has increased its indirect economic interest in Toscana Aeroporti S.p.A. by 15.6%, further strengthening its strategic position in the Italian airport sector.

CAAP

Corporación América Airports Acquires Remaining 25% Stake In Corporación América Italia, Secures 100% Ownership

Nvidia Corporation&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) is reportedly facing bipartisan criticism from U.S. senators over its plans to establish a facility in China, with concerns raised about the potential transfer of advanced technology to the country.
What Happened:&nbsp;Senators&nbsp;Jim Banks&nbsp;(R-Ind.) and&nbsp;Elizabeth Warren&nbsp;(D-Mass.) have written to Nvidia&#8217;s CEO&nbsp;Jensen Huang&nbsp;expressing their apprehensions about the company&#8217;s Shanghai facility,&nbsp;<a href="https://www.wsj.com/politics/senators-bash-nvidias-plans-for-facility-in-china-6f581018">reported</a>&nbsp;The Wall Street Journal on Thursday. The senators have asked for a detailed timeline and overview of the facility's plans, including specific research and engineering initiatives, as well as any financial incentives involved.
The facility "raises significant national security and economic security issues that warrant serious review," the Senators wrote in the letter.&nbsp; An Nvidia spokesperson stated that the company is only&nbsp;leasing a new space for&nbsp;its existing employees, with no plans to send advanced chip designs to the facility. The company is currently navigating the U.S.-China tech war and has been criticized by China hawks for its overseas activities.
The company is trying to balance access to the world&#8217;s two largest economies while adhering to export restrictions. Nvidia&#8217;s overseas moves are under scrutiny due to fears that its artificial intelligence chips could fall into the hands of adversaries.
SEE ALSO:&nbsp;<a href="https://benzinga.com/markets/25/05/45664337/china-tells-us-to-entirely-revoke-wrongful-unilateral-tariffs-after-court-blocks-trumps-liberation-day-levies" target="_blank" rel="noreferrer noopener">China Tells US To &#8216;Entirely&#8217; Revoke &#8216;Wrongful Unilateral&#8217; Tariffs After Court Blocks Trump's ‘Liberation Day' Levies &#8211; Benzinga</a>
Why It Matters: Earlier this month, reports emerged that Nvidia is considering a site in Shanghai for an R&amp;D center. As per Reuters, U.S. chipmaker Nvidia began site scouting in early 2025, focusing on Shanghai&#8217;s Minhang and Xuhui districts. The project accelerated following a surprise visit to China by CEO Jensen Huang last month.
Nvidia&#8217;s relationship with China has been a topic of discussion in the past. In May 2025, Nvidia CEO Jensen Huang <a href="https://www.benzinga.com/25/05/45513246/nvidia-ceo-jensen-huang-says-chinese-ai-researchers-are-world-class-and-us-companies-are-hiring-a-whole-bunch-of-them">criticized </a>U.S. chip export curbs as counterproductive to America&#8217;s technological leadership. He praised Chinese artificial intelligence researchers as &#8220;world-class&#8221;.
On Wednesday, Nvidia reported a strong first quarter, despite the China <a href="https://www.benzinga.com/news/earnings/25/05/45657660/nvidia-q1-highlights-china-export-ban-hits-results-but-jensen-huang-says-demand-incredibly-strong">export ban</a> impacting results. Huang stated that demand was &#8216;incredibly strong.&#8217; This shows the importance of the Chinese market to Nvidia&#8217;s business.
Nvidia stock climbed 5.1% in the Thursday pre-market. Over the past year, it surged 17.4%, as per data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/personal-finance/25/05/45665342/social-security-is-the-main-source-of-income-for-retirees-in-these-10-states-is-your-state-on-the-list" target="_blank" rel="noreferrer noopener">Social Security Is The Main Source Of Income For Retirees In These 10 States: Is Your State On The List? &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Markets

Tech

NVDA

Nvidia Faces Bipartisan Heat Over Its Shanghai Facility Amid 'Significant' National And Economic Security Threat: Report

ARBB

ARB IOT Group shares are trading lower after the company announced a 1-for-15 reverse stock split.

Health Care

Press Releases

Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis

Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update

Management

Gyre Therapeutics Announces the Appointment of Ping Zhang to Board of Directors

Gyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Gyre Therapeutics Announces Publication of Protocol for Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis in Journal of Clinical and Translational Hepatology

Gyre Therapeutics Announces NMPA Approval for Clinical Trial Evaluating Pirfenidone Capsules in Oncology-Related Pulmonary Complications

Gyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Gyre Therapeutics' Hydronidone Met the Primary Endpoint and Demonstrated Statistically Significant Fibrosis Regression in Pivotal Phase 3 Trial for the Treatment of CHB-associated Liver Fibrosis in China

Financing

Gyre Therapeutics Announces Proposed Underwritten Public Offering of Common Stock

Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock

Comments

Gyre Therapeutics

Gyre Therapeutics (GYRE) オプション

Gyre Therapeutics (NASDAQ:GYRE) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル